Document ID: chunk:federal_register_of_legislation:F2025C00036:reg:1
Version: federal_register_of_legislation:F2025C00036
Segment Type: reg
Provision Reference: reg 1
Character Range: 211965–213544

1                            (a) cannabidiol comprises 98% or more of the total cannabinoid content of the medicine; and                                                                                             liquid       oral                     (a) treatment of refractory chronic pain in adult patients; or
                             (b) any cannabinoids, other than cannabidiol, in the medicine are only those naturally found in cannabis and comprise 2% or less of the total cannabinoid content of the medicine; and                                        (b) treatment of refractory anxiety in adult patients; or
                             (c) the medicine contains no other active ingredients                                                                                                                                                                         (c) treatment of refractory sleep disorders in adult patients; or
                                                                                                                                                                                                                                                           (d) treatment of autism spectrum disorder in adult patients; or
                                                                                                                                                                                                                                                           (e) treatment and management of refractory cancer pain in adult patients